Strokes and Tricuspid - Cardiovascular Update

Smidt Heart Institute Physicians Advance Transcatheter Tricuspid Valve Replacement

DAIC

FEBRUARY 9, 2024

Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. The first 100 minimally invasive tricuspid procedures were done as part of the TRISCEND II clinical trial. Image by Getty. Image by Getty. Food and Drug Administration (FDA).

Tricuspid

Tricuspid Open-Heart Surgery Interventional Cardiology Bicuspid/Mitral

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

FEBRUARY 15, 2024

Food and Drug Administration ( FDA ) confirmed 13 to 1, with 0 abstention that the benefits of Abbott's TriClip™ transcatheter edge-to-edge repair (TEER) system outweighed the risks for the treatment of people with tricuspid regurgitation (TR). On the final question of the benefit of TriClip versus the risk, the vote was 13 to 1 in favor.

Tricuspid

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

DAIC

APRIL 30, 2024

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5%

TAVR

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Abstract 4143671: Transcatheter annuloplasty of tricuspid regurgitation with the K-Clip system: one-year results from the TRISTAR study.

Circulation

NOVEMBER 11, 2024

At 1 year, echocardiography showed average reductions of annular septolateral diameter by 11.3% (41.9mm vs. 37.1mm, p < 0.001) with increases in stroke volume(60.8±18.5mL Tricuspid regurgitation was reduced to ≤moderate in 82.5% female, mean TRISCORE 5.3±2.1). female, mean TRISCORE 5.3±2.1). 18.5mL vs 67.6±19.8mL,

Tricuspid

Tricuspid Quality of Life Heart Failure Cardiomyopathy

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

The study aims to compare the outcomes of transcatheter aortic valve replacement for AS in patients with type 0 bicuspid, type 1 bicuspid, and tricuspid aortic valve anatomy.METHODS:We enrolled consecutive patients undergoing transcatheter aortic valve replacement for severe AS between 2012 and 2022 in this single-center retrospective cohort study.

Aortic valve

Aortic valve Bicuspid/Mitral Aortic Tricuspid

Use of Direct?Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Significant Tricuspid Regurgitation

Journal of the American Heart Association

JANUARY 31, 2024

BackgroundThere are limited data on the efficacy and safety of direct oral anticoagulants (DOACs) in patients with atrial fibrillation with significant tricuspid regurgitation (TR), which can lead to hepatic dysfunction and intestinal malabsorption. Journal of the American Heart Association, Ahead of Print. 1.06];P=0.11).

Atrial Fibrillation

Atrial Fibrillation Tricuspid Embolism Hemorrhage

Implications of tricuspid regurgitation and right ventricular volume overload in patients with heart failure with preserved ejection fraction

European Journal of Heart Failure

MARCH 11, 2024

Abstract Aims The aim of this study was to assess the pathophysiological implications of severe tricuspid regurgitation (TR) in patients with heart failure with preserved ejection fraction (HFpEF) by using tricuspid transcatheter edge-to-edge repair (T-TEER) as a model of right ventricular (RV) volume overload relief.

Preserved Ejection Fraction

Preserved Ejection Fraction Tricuspid Heart Failure Physiology

Pulsed‐Field Ablation for Persistent Atrial Fibrillation in EU‐PORIA Registry

Journal of Cardiovascular Electrophysiology

APRIL 2, 2025

In the PVI + group, extra PV ablation included left atrial posterior wall isolation (87%), mitral isthmus ablation (37%), and cavo-tricuspid isthmus ablation (3%). versus 1.0% (PVI only vs. PVI + ), including pericardial tamponade (6 vs. 0; p =0.345) and stroke (1 vs. 1; p =0.400). Major complications occurred in 2.0%

Atrial Fibrillation

Atrial Fibrillation Ablation Tachycardia Tricuspid

Transcatheter versus surgical valve replacement in patients with bicuspid aortic valves: an updated meta-analysis

The British Journal of Cardiology

FEBRUARY 20, 2024

Single-arm studies, conference presentations, animal studies, and studies that involved patients with tricuspid aortic morphology were excluded. Medical databases were queried to pool comparative studies of interest. Outcomes were pooled as risk ratios (RRs) with their 95% confidence intervals (CI) using the random effects model in R.

Aortic valve

Aortic valve Bicuspid/Mitral Aortic TAVR

Taskforce Develops New Standards to Monitor Adults with Heart Valve Disease

DAIC

FEBRUARY 18, 2025

Patients with aortic/mitral/tricuspid valve disease or root/ascending aorta >40 mm were included as soon as they were diagnosed with heart valve disease.

Heart Valves

Heart Valves Quality of Life Cardiothoracic Outcomes

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes.

Tricuspid

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics

Right heart failure as a cause of pulmonary congestion in pulmonary arterial hypertension

European Journal of Heart Failure

FEBRUARY 26, 2024

CI, cardiac index; FC, functional class; IQR, interquartile range; NT-proBNP, N-terminal pro-brain natriuretic peptide; PVR, pulmonary vascular resistance; sPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; WHO, World Health Organization.

Pulmonary

Pulmonary Heart Failure Hypertension Ultrasound

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

TCT 2024’s Top TAVR Studies

CardiacWire

NOVEMBER 3, 2024

This year’s TCT conference saw a deluge of TAVR studies examining everything from the efficacy of valve designs to TAVR’s impact on aortic and tricuspid regurgitation. The study revealed significant stroke risk reductions with U.S.-performed

TAVR

TAVR Embolism Interventional Cardiology Aortic

Right ventricular dysfunction and impaired right ventricular–pulmonary arterial coupling in paradoxical low‐flow, low‐gradient aortic stenosis

European Journal of Heart Failure

DECEMBER 19, 2024

AF, atrial fibrillation; LAVI, left atrial volume index; RA, right atrial; RV, right ventricular; sPAP, systolic pulmonary artery pressure; SVI, stroke volume index; TR, tricuspid regurgitation. RVD was common and associated with a significantly higher all-cause mortality after TAVI.

Stenosis

Stenosis Aortic Pulmonary Aortic valve

Smidt Heart Institute Physicians Advance Transcatheter Tricuspid Valve Replacement

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

Webinars

Abstract 4143671: Transcatheter annuloplasty of tricuspid regurgitation with the K-Clip system: one-year results from the TRISTAR study.

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Use of Direct?Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Significant Tricuspid Regurgitation

Implications of tricuspid regurgitation and right ventricular volume overload in patients with heart failure with preserved ejection fraction

Pulsed‐Field Ablation for Persistent Atrial Fibrillation in EU‐PORIA Registry

Transcatheter versus surgical valve replacement in patients with bicuspid aortic valves: an updated meta-analysis

Taskforce Develops New Standards to Monitor Adults with Heart Valve Disease

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices

Right heart failure as a cause of pulmonary congestion in pulmonary arterial hypertension

Published Research

Published Research

TCT 2024’s Top TAVR Studies

Right ventricular dysfunction and impaired right ventricular–pulmonary arterial coupling in paradoxical low‐flow, low‐gradient aortic stenosis

Stay Connected